Cost-Effectiveness of Frailty-Adjusted Therapy in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma - an Economic Evaluation of the Fitness Trial

Dawkins, B., Gkountouras, G., Meads, D. et al. (21 more authors) (2024) Cost-Effectiveness of Frailty-Adjusted Therapy in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma - an Economic Evaluation of the Fitness Trial. [Conference abstract]

Metadata

Item Type: Conference abstract
Authors/Creators:
  • Dawkins, B.
  • Gkountouras, G.
  • Meads, D.
  • Pawlyn, C.
  • Royle, K.-L.
  • Senior, E.R.
  • Everritt, D.
  • Bird, J.
  • Bowcock, S.
  • Drayson, M.
  • Gillson, S.
  • Olivier, C.
  • Jenner, M.W.
  • Jones, J.R.
  • Kaiser, M.F.
  • Kishore, B.
  • Rabin, N.
  • Owen, R.G.
  • de Tute, R.M.
  • Parrish, C.
  • Cairns, D.A. ORCID logo https://orcid.org/0000-0002-2338-0179
  • Chant, A.
  • Jackson, G.
  • Cook, G.
Dates:
  • Published: 5 November 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Funding Information:
Funder
Grant number
Cancer Research UK Supplier No: 138573
A25447
Cancer Research UK Supplier No: 138573
CTUQQR-Dec22/100002
NIHR National Inst Health Research
Not Known
Takeda UK Ltd. Building 3, Glory Park
Not Known
Millennium Pharmaceuticals Inc.
X160111
Cancer Research UK Supplier No: 138573
A24078
Date Deposited: 15 Jan 2025 13:14
Last Modified: 05 Mar 2026 12:12
Status: Published
Publisher: American Society of Hematology
Identification Number: 10.1182/blood-2024-209720
Sustainable Development Goals:
  • Sustainable Development Goals: Goal 3: Good Health and Well-Being
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)